Modulation of succinyl‐ CoA :3‐ketoacid CoA transferase activity by a single amino acid residue in acetate:succinate CoA transferase from Trypanosoma brucei , the causative agent of African sleeping sickness
Protein Science · 2026
DOI: 10.1002/pro.70463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2026. Verfasst von Kota Mochizuki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan. Hauptthemen laut MEDLINE: Trypanosoma brucei brucei, Coenzyme A-Transferases, Protozoan Proteins. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Research Partnership for Sustainable Development, Japan Society for the Promotion of Science, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Trypanosomatids are protozoan parasites that remain a global health challenge due to the limited efficacy, safety, and durability of current treatments. Acetate: succinate CoA transferase (ASCT), together with succinyl‐CoA synthase (SCS), forms the ASCT/SCS cycle that fuels ATP production and generates acetate, a central metabolic intermediate essential for mitochondrial pathways in these parasites. Although Trypanosoma brucei ASCT (TbASCT) shares 52% amino acid identity with mammalian succinyl‐CoA:3‐ketoacid CoA transferase (mSCOT), the latter catalyzes a rate‐limiting step of ketone body catabolism. Because ASCT and SCOT perform distinct reactions, understanding their mechanistic divergence is crucial for identifying parasite‐specific vulnerabilities and advancing selective drug discovery. Here, we report crystal structures of TbASCT bound to all substrates and products, revealing the molecular basis of substrate recognition and catalysis. In solution, TbASCT and mSCOT are homotetrameric and homodimeric, respectively. Despite similar monomer fold, the substrate‐binding sites and catalytic mechanisms by which these two enzymes mediate different reactions remain unknown. Site‐directed mutagenesis demonstrated that residues Arg162, Leu377, and Asp62 govern tetramer assembly, CoA binding, and acquisition of SCOT activity, respectively. Mutation of Leu377 abolished ASCT activity, while Arg162 mutant produced ASCT‐active dimers with a 10‐fold increase in SCOT/ASCT activity ratio. Notably, Asp62 mutants exhibited more than 4000‐fold increase in this ratio, representing gain‐of‐function SCOT activity, a reaction absent in TbASCT. These mechanistic insights define the structural determinants that separate ASCT from SCOT function and illuminate opportunities to selectively inhibit ASCT without disrupting host SCOT, thereby informing the development of trypanosomatid‐targeted therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
- Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
- Department of Medical Zoology, Kanazawa Medical University, Ishikawa, Japan.
- School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
- Department of Biomedical Chemistry, School of International Health, University of Tokyo, Tokyo, Japan.
- Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
ORCID-Profile: Daniel Ken Inaoka, Tomoo Shiba
Förderung
- Science and Technology Research Partnership for Sustainable Development
- Japan Society for the Promotion of Science
- Agence Nationale de la Recherche
- Japan Agency for Medical Research and Development (Strategic Japanese-French Cooperative Program No 1)
- FIC NIH HHS
- Centre National de la Recherche Scientifique (Université de Bordeaux)
- Université de Bordeaux
Zitieren
APA
Mochizuki, K., Inaoka, D. K., Fukuda, K., Kurasawa, H., Iyoda, K., Nakai, U., Harada, S., Balogun, E. O., Bringaud, F., Boshart, M., Sakura, T., Hirayama, K., Kita, K., & Shiba, T. (2026). Modulation of succinyl‐ CoA :3‐ketoacid CoA transferase activity by a single amino acid residue in acetate:succinate CoA transferase from Trypanosoma brucei , the causative agent of African sleeping sickness. Protein Science. https://doi.org/10.1002/pro.70463
Vancouver
Mochizuki K, Inaoka DK, Fukuda K, Kurasawa H, Iyoda K, Nakai U, et al. Modulation of succinyl‐ CoA :3‐ketoacid CoA transferase activity by a single amino acid residue in acetate:succinate CoA transferase from Trypanosoma brucei , the causative agent of African sleeping sickness. Protein Science. 2026. doi:10.1002/pro.70463
BibTeX
@article{Mochizuki2026,
author = {Mochizuki, Kota and Inaoka, Daniel Ken and Fukuda, Keisuke and Kurasawa, Hana and Iyoda, Kenji and Nakai, Uta and Harada, Shigeharu and Balogun, Emmanuel O and Bringaud, Frédéric and Boshart, Michael and Sakura, Takaya and Hirayama, Kenji and Kita, Kiyoshi and Shiba, Tomoo},
title = {Modulation of succinyl‐ CoA :3‐ketoacid CoA transferase activity by a single amino acid residue in acetate:succinate CoA transferase from Trypanosoma brucei , the causative agent of African sleeping sickness},
journal = {Protein Science},
year = {2026},
doi = {10.1002/pro.70463}
}
EUVIMED